Showing results (261-270 of 424) with videos related to
Sort By:
Pageof 43
The Journal of Biological Chemistry|October 15, 2013
Chemotype-selective modes of action of κ-opioid receptor agonistsEyal Vardy, Philip D Mosier, Kevin J Frankowski, et al.Proceedings of the National Academy of Sciences of the United States of America|June 20, 2012
Identifying mechanism-of-action targets for drugs and probesElisabet Gregori-Puigjané, Vincent Setola, Jérôme Hert, et al.Journal of Medicinal Chemistry|March 17, 2009
Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like actionSung Jin Cho, Niels H Jensen, Toru Kurome, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 7, 2003
Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivoAlan I Faden, Susan M Knoblach, Ibolja Cernak, et al.Cell|February 22, 2011
Endocrine regulation of male fertility by the skeletonFranck Oury, Grzegorz Sumara, Olga Sumara, et al.The Journal of Pharmacology and Experimental Therapeutics|March 12, 2005
Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administrationRichard B Rothman, Bruce E Blough, William L Woolverton, et al.Plos Biology|December 12, 2018
Far away from the lamppostTudor I Oprea, Lily Jan, Gary L Johnson, et al.Journal of Medicinal Chemistry|August 1, 2012
Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonistsXin Chen, Maria F Sassano, Lianyou Zheng, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 12, 2003
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugsWesley K Kroeze, Sandra J Hufeisen, Beth A Popadak, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 16, 2017
5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in MiceVladimir M Pogorelov, Ramona M Rodriguiz, Jianjun Cheng, et al.Pageof 43